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Abstract
Angiogenesis requires coordinated changes in cell shape of endothelial cells (ECs), orchestrated by the actin cytoskeleton.
The mechanisms that regulate this rearrangement in vivo are poorly understood - largely because of the difficulty to
visualize filamentous actin (F-actin) structures with sufficient resolution. Here, we use transgenic mice expressing Lifeact-
EGFP to visualize F-actin in ECs. We show that in the retina, Lifeact-EGFP expression is largely restricted to ECs allowing
detailed visualization of F-actin in ECs in situ. Lifeact-EGFP labels actin associated with cell-cell junctions, apical and basal
membranes and highlights actin-based structures such as filopodia and stress fiber-like cytoplasmic bundles. We also show
that in the skin and the skeletal muscle, Lifeact-EGFP is highly expressed in vascular mural cells (vMCs), enabling vMC
imaging. In summary, our results indicate that the Lifeact-EGFP transgenic mouse in combination with the postnatal retinal
angiogenic model constitutes an excellent system for vascular cell biology research. Our approach is ideally suited to
address structural and mechanistic details of angiogenic processes, such as endothelial tip cell migration and fusion, EC
polarization or lumen formation.
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Introduction
The actin cytoskeleton is composed of actin filaments (F-actin),
which are constantly remodelled and are essential for the de-
velopment of specialised cellular structures, such as filopodia,
lamellipodia and stress fibers [1]. Reliable visualization of F-actin is
therefore critical tounderstand themechanisms that regulate cellular
actin dynamics as well as actin-dependent cellular processes, such as
morphogenesis, polarity, movement and cytokinesis [1]. The actin
cytoskeleton also serves as a scaffold for signalling, a connectionwith
the extracellular matrix (ECM) and a mechanosensor. Despite its
importance, the structural organization, dynamics and regulation of
F-actin in mammals in vivo are not well understood.
Sprouting angiogenesis, the formation of new blood vessels from
pre-existing ones, is required for organogenesis and contributes to
the progression of many diseases including cancer [2]. Vessel
sprouting involves several morphogenetic steps, during which
endothelial cells (ECs) polarize, migrate, establish cell-cell contacts
and form vessel lumens [2]. These processes are critically
dependent on the organization and dynamic rearrangement of
the endothelial actin cytoskeleton [3,4,5,6]. A lack of tools for in
vivo imaging of F-actin structures in individual ECs in mammals
has so far precluded an understanding of how ECs regulate the
actin cytoskeleton during angiogenesis. Our knowledge on the
organization and regulation of the endothelial actin cytoskeleton is
mainly based on in vitro studies, which are missing essential
physiological features, such as composition of the ECM, blood
flow and mechanical input from the tissue [7].
Lifeact is a 17-amino-acid-long actin-binding peptide derived
from yeast that specifically labels F-actin without affecting actin
organization. It has been extensively used to visualize F-actin and
to study actin dynamics in vitro and in vivo [8,9]. Recently,
transgenic mice ubiquitously expressing Lifeact fused to enhanced
green fluorescent protein (EGFP) have been generated (Lifeact-
EGFP mice), allowing visualization of F-actin in tissues and whole
animals [10]. The utility of Lifeact-EGFP mice for vascular
research has not been reported. Here we report an extensive
analysis of the expression patterns of Lifeact-EGFP in the vascular
system from the Lifeact-EGFP mice and show that: 1) in the
retinas, Lifeact-EGFP is extremely useful for the analysis of
endothelial actin-remodelling during vessel growth and 2) in the
skin and the skeletal cremaster muscle, Lifeact-EGFP is a powerful
tool for imaging vascular mural cells (vMCs). In summary, our
data indicate that the Lifeact-EGFP transgenic mouse is an
excellent tool for vascular cell biology research.
Methods
Animals
Lifeact-EGFP transgenic mice have been previously described
[10]. The expression of Lifeact-EGFP is driven by a chicken actin
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promoter under the influence of a CMV enhancer ensuring
ubiquitous expression [11]. All experiments with mice were
performed in accordance to German guidelines and regulations.
The protocols were approved by the Committee on the Ethics of
Animal Experiments of the Ludwig-Maximilians University
Munich.
Whole Embryo Immunohistochemistry
Embryos were dissected in PBS at embryonic day (E) 10.5 and
fixed overnight in fixation buffer (80% methanol, 20% DMSO).
Embryos were stained as whole mounts as previously described
[12].
Analysis of Angiogenesis in the Postnatal Mouse Retina
Eyes were collected between postnatal (P) day 5 and P10 and
fixed in 4% paraformaldehyde (PFA) for 2 hours at room
temperature. Retinas were dissected and stained as whole mounts
as previously described [13]. Table S1 details information about
reagents and antibodies used for staining. Images were acquired
and processed using a Leica TCS SP5 II microscope, LAS
Montage Imaging software (Leica) and the IMARIS Digital
Imaging software (Biplane). Wide-field images were acquired using
DeltaVision OMX V3 microscope (Applied Precision) in conven-
tional mode and Cascade II:512 EMCCD cameras (Photometrics).
SoftWoRx software (Applied Precision) was used for deconvolving
the images with enhanced additive method.
Skin Immunohistochemistry
Samples were collected, fixed and stained as previously
described [14].
Immunohistochemistry and in vivo Microscopy of
Skeletal Muscle
Microsurgical preparation of the cremaster muscle and in vivo
microscopy was performed as described previously [15]. Briefly,
mice were anesthetized using a ketamine/xylazine mixture
(100 mg/kg ketamine and 10 mg/kg xylazine), administrated by
intraperitoneal injection. The right cremaster muscle was exposed
through a ventral incision of the scrotum. The muscle was opened
ventrally in a relatively avascular zone, using careful electrocautery
to stop any bleeding, and spread over the pedestal of a custom-
made microscopy stage. Epididymis and testicle were detached
from the cremaster muscle and placed into the abdominal cavity.
Throughout the procedure as well as after surgical preparation
during in vivo microscopy, the muscle was superfused with warm
buffered saline. After in vivo microscopy, the tissue was fixed in 2%
paraformaldehyde and immunostained as whole mount.
In vivo Microscopy
The setup for in vivo microscopy was centered on an AxioTech-
Vario 100 Microscope (Zeiss), equipped with LED excitation light
(Zeiss) for fluorescence epi-illumination. Microscopic images were
obtained with a water dipping objective (20x, NA 0.5) and
acquired with an AxioCam Hsm camera and Axiovision 4.6
software.
Results and Discussion
The expression level and cellular expression pattern of Lifeact-
EGFP in the vascular system of the Lifeact-EGFP mice is not
known. Mouse embryos and early postnatal mouse retinas are in
vivo models extensively used to study the mechanisms that regulate
EC behaviour during angiogenesis [13]. To determine the
expression of Lifeact-EGFP in ECs, we first analysed embryos
and retinas of Lifeact-EGFP mice. To this end, we performed
whole-mount immunostaining of E10.5 embryos with an antibody
against CD31 to visualize ECs. In embryos, we find that Lifeact-
EGFP is ubiquitously expressed precluding adequate imaging of F-
actin structures in ECs (Figure S1). In the retina, the vascular
plexus develops in close association with a pre-existing network of
retinal astrocytes (ACs) [16]. To monitor Lifeact-EGFP expression
in retinas, we first performed whole-mount immunostaining of
retinas from postnatal day (P) 5 and P10 with isolectin B4 (IB4) to
stain ECs and an antibody against glial fibrillar protein (GFAP) to
visualize ACs. Lifeact-EGFP was highly expressed in ECs but
practically absent from ACs (Figure 1A and B). Immunostaining of
retinas with an antibody against the endothelial-specific marker
vascular endothelial cadherin (VECad) further confirmed the
endothelial identity of the Lifeact-EGFP-expressing cells
(Figure 1C and S2). Furthermore, Lifeact-EGFP was practically
absent from retinal tissue macrophages (TMs), which were positive
for IB4 [17] (Figure 2). Next, we determined whether Lifeact-
EGFP was expressed in retinal vascular mural cells (vMCs). For
this purpose, we performed immunostaining of retinas with
antibodies against alpha-smooth muscle actin (aSMA) and neuron
glial antigen 2 (NG2), to visualize vascular smooth muscle cells
(vSMCs) and pericytes (PCs), respectively. We found that Lifeact-
EGFP was weakly expressed in vSMCs, whereas it was practically
absent from PCs (Figure 3).
Next, we addressed the expression of Lifeact-EGFP in vascular
and lymphatic vessels in several organs from adult Lifeact-EGFP
mice. We performed whole-mount immunostaining of skin and
skeletal cremaster muscle using anti-CD31 and anti-aSMA
antibodies. Contrary to the retina, we found that in the skin and
the skeletal cremaster muscle, Lifeact-EGFP was highly expressed
in the vMCs but weakly in ECs (Figure 4). Moreover, we were not
able to detect Lifeact-EGFP in the lymphatic endothelium,
suggesting that in these cells Lifeact-EGFP is almost absent
(Figure 4E). The cremaster muscle is a well established in vivo
model to study dynamic morphogenetic microvascular events such
as leukocyte-EC interactions and leukocyte extravasation [18]. We
observed that the leukocytes from Lifeact-EGFP mice expressed
Lifeact-EGFP, enabling in vivo visualization of rolling and adherent
leukocytes at the vessel walls of postcapillary venules (Video S1).
Collectively, these results indicate that in postnatal retinas of
Lifeact-EGFP mice, Lifeact-EGFP is mainly expressed in the
vascular endothelium, allowing imaging of the endothelial actin
cytoskeleton with excellent contrast, and that in the skin and the
skeletal muscle, Lifeact-EGFP constitutes a powerful system to
visualize vMCs.
During sprouting angiogenesis, ECs within the sprouts special-
ize into distinct functional phenotypes [2]. Tip cells initiate new
sprouts, form extensive filopodia, migrate and fuse with other tip
cells. The highly proliferative stalk cells follow the tip cells,
elongate the stalk of the sprout, form the vessel lumen and
establish cell-cell junctions to maintain sprout integrity. Finally,
ECs lining the inner surface of consolidated vessels form a tight
cobblestone monolayer ensuring vessel perfusion. In the postnatal
retina, all stages of the sprouting process can be efficiently analysed
in a single sample owing to the spatiotemporal sequence of
angiogenic network formation [13]. To characterize Lifeact-EGFP
expression and to visualize F-actin in vascular ECs in situ, we first
stained whole-mounted retinas with fluorescent phalloidin, an F-
actin binding compound that labels retinal vascular and non-
vascular structures [19]. In agreement with previously published
data [19], phalloidin mainly stained the angiogenic front of the
vascular plexus where it highlighted leading edges and filopodia of
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the tip cells (Figure 5). The weak phalloidin stain in the ECs at the
central part of the vascular plexus, as well as the label of non-
vascular structures make the visualization of the endothelial actin
cytoskeleton in consolidated vessels difficult (Figure 5). Important-
ly, Lifeact-EGFP overlapped with phalloidin at the leading edges
of the vascular plexus and at the filopodia of tip cells (Figure 5).
However, in contrast to phalloidin stain, Lifeact-EGFP signal was
bright in the entire vascular plexus, enabling visualization of F-
actin in all types of specialized ECs (Figure 5). Together, our
results show that in the retina Lifeact-EGFP labels endothelial F-
actin in higher grade and better signal-to-noise ratio compared to
phalloidin.
The planar outgrowth of the inner vasculature in the retina
allows high-resolution three-dimensional imaging of the endothe-
lium [7]. To visualize and characterize the actin cytoskeleton in
ECs, we performed high-resolution confocal laser scanning
microscopy (Figure 6A, D and E) and high-power deconvolution
imaging (Figure 6B and C) of sprouting vessels in P6 retinas from
Lifeact-EGFP mice. We found that in migrating tip cells, Lifeact-
EGFP brightly labelled cortical actin, filopodia as well as long and
thin actin bundles in the cytoplasm resembling stress fibers
(Figure 6A and B). In stalk cells, Lifeact-EGFP highlighted
endothelial junctions (Figure 6C) and short filopodial-like protru-
sions along the cell membrane (Figure 6D). Lifeact-EGFP
demarcation allowed a morphometric analysis of these actin
protrusions; they had a length of 3.5 mm 60.61 mm (n= 50).
Similar protrusions were also observed in EC in the established
plexus (Figure S2) and in anastomosing tip cells at the fusion points
(Figure S3). Next, we labelled lumenized vessels with an antibody
against intercellular adhesion molecule 2 (ICAM-2), a marker for
Figure 1. Lifeact-EGFP is highly expressed in endothelial cells but practically absent from astrocytes in the postnatal retinas of
Lifeact-EGFP mice. IB4 (A in red), GFAP (B in red) or VECad (C in red) staining of whole-mounted P5 retinas. Lifeact-EGFP: green. Scale bars: A:
100 mm, B: 100 mm, C: 50 mm. af: angiogenic front; cp: central plexus; at: artery; vn: vein.
doi:10.1371/journal.pone.0047488.g001
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the luminal EC membrane [20]. We found that Lifeact-EGFP
partially localizes adjacent to ICAM-2 stain (Figure 6E), indicating
that Lifeact-EGFP marks F-actin along the luminal as well as the
abluminal membrane of the endothelium. This localization
Figure 2. Lifeact-EGFP expression is nearly absent in retinal tissue macrophages. IB4 (in red) staining of whole-mounted P5 (A) and P10 (B)
retinas. Lifeact-EGFP: green. Arrows point to IB4-positive tissue macrophages. Scale bars: 20 mm.
doi:10.1371/journal.pone.0047488.g002
Figure 3. Lifeact-EGFP is weakly expressed in the vascular mural cells of the retinal vasculature. aSMA (A in red) or NG2 (B in red)
staining of whole-mounted P5 retinas. Lifeact-EGFP: green. Arrows point to aSMA-positive cells (A) and NG2-positive pericytes (B). Scale bars: A:
50 mm, B: 20 mm and 50 mm.
doi:10.1371/journal.pone.0047488.g003
Imaging of Endothelial Actin Cytoskeleton
PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e47488
Imaging of Endothelial Actin Cytoskeleton
PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e47488
pattern is well suited for future studies of EC apical-basal polarity.
Together, our results using Lifeact-EGFP identified actin-based
protrusions and filopodia, actin-enriched cell membrane regions
and cytoplasmic F-actin structures in ECs within sprouting and
consolidated vessels.
In summary, the results presented here show that the Lifeact-
EGFP mouse in combination with the early postnatal retinal
angiogenic model is an excellent system to visualize and
characterize the actin cytoskeleton in individual ECs in situ. We
believe that these mice will be a great resource for vascular
Figure 4. The skin and the cremaster muscle of Lifeact-EGFP mice are powerful systems to visualize F-actin of vascular mural cells.
CD31 (in red) staining of whole-mounted tail skin (A) and ear (C and E). Lifeact-EGFP: green. (B and D) aSMA (in red) and CD31 (in blue) double
labelling of blood vessels in the cremaster muscle. Lifeact-EGFP: green. Arrows point to endothelium and arrowheads point to vascular mural cells.
Scale bars: A: 100 mm, B: 100 mm, C: 20 mm, D: 15 mm, E: 100 mm. at: artery; cp: capillaries; hf: hair follicle; lym: lymphatic endothelium; m: muscle.
doi:10.1371/journal.pone.0047488.g004
Figure 5. Lifeact-EGFP colocalize with phalloidin. Phalloidin (in red) staining of whole-mounted P6 retina. The leading edges of tip cells are
highly enriched in actin filaments (arrows). Lifeact-EGFP: green. Scale bars: 10 and 50 mm.
doi:10.1371/journal.pone.0047488.g005
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research and can be used for the study of morphogenetic
angiogenic processes such as migration, polarization and anasto-
mosing of ECs as well as lumen formation.
Supporting Information
Figure S1 Lifeact-EGFP is ubiquitously expressed dur-
ing embryogenesis. CD31 (in red) staining of whole-mounted
E10.5 transgenic Lifeact-EGFP embryos. Lifeact-EGFP: green. (A)
3-dimensional reconstruction images. (B) Confocal sections.
Arrows point to intersomitic vessels and arrowheads indicate
epithelial actin-rich apical site. Scale bars: 50 mm. Ep: Epithelial
cell; Me: Mesenchymal cell; NT: Neural tube.
(TIF)
Figure S2 Lifeact-EGFP expression is practically absent
in retinal astrocytes. GFAP (in red) and VECad (blue) double
labelling of retinas. Lifeact-EGFP: green. Arrowheads indicate
short actin filament protrusions in ECs. Scale bars: 20 mm.
(TIF)
Figure S3 Confocal images of endothelial actin cyto-
skeleton in retinal vasculature. (A and B) Visualization of
endothelial actin cytoskeleton (Lifeact-EGFP: white) during
anastomosing of tip cells. Arrowheads point to short actin filament
protrusions during the tip cell fusion process. (C) 3-dimensional
reconstruction of an EC sprout. Lifeact-EGFP: white. Arrow
points to an actin filament protrusion. Scale bars: 20 mm.
(TIF)
Table S1 Antibodies and reagents used for staining.
(DOCX)
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Figure 6. Lifeact-EGFP labels cortical actin, filopodia and cytoplasmic actin bundles in tip and stalk endothelial cells. (A) Migrating tip
cells. Arrows indicate tip cell filopodia, white arrowheads point to F-actin filaments in the cytoplasm and red arrowheads point to cortical actin. High-
magnification deconvolution images of tip cell (B) and stalk cells (C) showing details of actin cytoskeleton organization (Lifeact-EGFP: green), with
fine actin-rich filopodia protrusions and cortical actin cables, running along adherens junctions (VECad: red) (D) VECad (in red) and aSMA (in blue)
double labelling of a vascular sprout. Lifeact-EGFP: green. Arrowheads indicate short actin filament protrusions in stalk cells. (E) Optical section of
retinal vasculature stained with ICAM-2 (in red). Lifeact-EGFP: green. Arrowheads point to the luminal endothelial membrane and the asterisk marks
the abluminal side of a vessel. Scale bars: A: 30 mm, B: 5 mm, C: 5 mm, D: 10 mm, E: 20 mm.
doi:10.1371/journal.pone.0047488.g006
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